May 10, 2024 – Talk Bio

Revolutionizing Healthcare: Streamlining Cell and Gene Therapy Manufacturing (Part 1)

12 months ago talkbio0Tagged Biotechnology, Cell Therapy, Cost Effectiveness, gene therapy, healthcare innovation, Manufacture, Precision Medicine, production, regulatory, scalability

Cell therapy, gene therapy, manufacturing, biotechnology, healthcare innovation, personalized medicine, production challenges, regulatory compliance, scalability, cost-effectiveness.

Moderna’s RSV Vaccine Decision Postponed by FDA to Late May

12 months ago talkbio0Tagged Decision, May, Moderna, Respiratory syncytial virus, United States Food and Drug Administration, Vaccines

FDA, Moderna, RSV vaccine, decision, delay, May

Revolutionizing Medicine: The Evolution and Future of Cell and Gene Therapy Manufacturing

12 months ago talkbio0Tagged Automation, biomanufacturing, CAR-T, Cell Therapy, gene therapy, Manufacture, Precision Medicine, regulatory, scale-up, Stem Cell Therapy, Viral Vector

Cell therapy manufacturing, gene therapy manufacturing, biomanufacturing, advanced therapies, CAR-T cell therapy, stem cell therapy, viral vectors, bioreactors, automation, scale-up, regulatory compliance, personalized medicine.

Shionogi Acquires Maze’s Pompe Disease Drug Following FTC’s Sanofi Deal Halt

12 months ago talkbio0Tagged drug acquisition, Glycogen storage disease type II, Maze, sanofi, shionogi, United States Federal Trade Commission

Shionogi, Maze, Pompe disease, drug acquisition, FTC, Sanofi, $150 million

Revolutionary Gene Insertion Techniques Unveiled at #ASGCT24: A Glimpse into the Future of Genetic Engineering

12 months ago talkbio0Tagged ASGCT24, Closed Doors, gene insertion techniques, Genetic Engineering, Scientist, startups

Gene Insertion Techniques, #ASGCT24, Genetic Engineering, Scientists, Startups, Closed Doors

Sanofi Invests $500M in Novavax’s Covid Vaccine, Exploring Commercialization and Flu Combination

12 months ago talkbio0Tagged Combined, commercialization, Covid Vaccine, Investments, Novavax, sanofi

Sanofi, Novavax, Covid vaccine, commercialization, flu combination, $500M investment

MacroGenics Reviews Safety Protocols Following Three Patient Deaths in Prostate Cancer Drug Trial

12 months ago talkbio0Tagged Antibodies, Bispecific, Cessation of life, MacroGenics, Malignant neoplasm of prostate, margetuximab, Phase 2 trial, safety review

MacroGenics, Phase 2 trial, prostate cancer, patient deaths, safety review, margetuximab, bispecific antibody

Novo Nordisk and Metaphore Pharmaceuticals Join Forces in a $600 Million Partnership to Pioneer Innovative Obesity Treatments

12 months ago talkbio0Tagged Metabolic Diseases, next-generation, Nordisk, Obesity, Partnership, pharmaceutical collaboration, weight loss medications

Novo Nordisk, Metaphore Pharmaceuticals, obesity drugs, next-generation treatments, $600 million deal, partnership, pharmaceutical collaboration, weight loss medications, metabolic disorders.